As of January 2025, Samsung Biologics has a market cap of $45.78B. This makes Samsung Biologics the world's 366th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $40.07B | 8.03% |
2023 | $37.09B | -7.43% |
2022 | $40.07B | -9.08% |
2021 | $44.07B | 9.32% |
2020 | $40.31B | 90.76% |
2019 | $21.13B | 12.03% |
2018 | $18.86B | 4.18% |
2017 | $18.11B | 145.70% |
2016 | $7.37B | - |